Abstract
Clinical results show that raloxlfene benefits heart and bone in postmenopausal women without increasing the risk of uterine cancer but its long-term effects are unknown.
Original language | English (US) |
---|---|
Pages (from-to) | 152-153 |
Number of pages | 2 |
Journal | Nature Medicine |
Volume | 4 |
Issue number | 2 |
DOIs | |
State | Published - 1998 |
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)